login
login

Europe Daily Bulletin No. 12229

5 April 2019
Contents Publication in full By article 14 / 38
SECTORAL POLICIES / Health
Product authorisation procedures must be adapted for no-deal Brexit
Brussels, 04/04/2019 (Agence Europe)

The European Commission was trying to be reassuring when it presented, on Thursday 4 April, the impact of a no-deal Brexit on the health sector. There will be no shortage of medicines, promises Vice-President Jyrki Katainen, who nevertheless stresses that the procedures for authorising medicines and medical devices will have to be adapted. 

"A no-deal exit of the United Kingdom from the European Union will necessarily lead to changes in the health sector. The United Kingdom will no longer...

Contents

EUROPEAN PARLIAMENT PLENARY
SECTORAL POLICIES
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
COURT OF JUSTICE OF THE EU
EMPLOYMENT
NEWS BRIEFS